Pulmonary Hypertension Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Janssen Announces Update to Phase 3 MACiTEPH Study Evaluating Macitentan 75mg in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
RARITAN, NJ, September 6, 2023– The Janssen Pharmaceutical Companies of Johnson& Johnson today announced its decision to stop the Phase 3 MACiTEPH study evaluating macitentan 75 mg in patients with Chronic Thromboembolic Pulmonary... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 6, 2023 Category: Pharmaceuticals Source Type: clinical trials

Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure
Conditions: Right Heart Failure; Pulmonary Hypertension Interventions: Diagnostic Test: Echocardiography; Diagnostic Test: Right heart catheterization Sponsor: Jingyi Ren Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials

Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure
Conditions: Pulmonary Hypertension; Heart Failure Intervention: Procedure: Pulmonary Artery Denervation Sponsor: Pulnovo Medical (Wuxi) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials